ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "JACC - September 17, 2024 Issue Summary"
Episode Synopsis
In this episode, Valentin Fuster reviews the September 17, 2024, JACC issue, highlighting pivotal studies on metabolic surgery's impact on cardiovascular risk in obstructive sleep apnea patients, and the potential of DPP-4 inhibitors in aortic valve calcification. He also discusses the benefits of Sitagliptin for heart failure and the prognostic value of plasma immunoglobulins in pulmonary arterial hypertension, closing with a look at genotype-guided antiplatelet therapy.
More episodes of the podcast JACC This Week
December 2, 2025: Global CVD 1990–2023: Trends, Risks, and the Road Ahead | JACC This Week
24/11/2025
November 18, 2025: Adiposity, Heart Failure, and the Future of Cardiometabolic Care | JACC This Week
10/11/2025
November 11, 2025: Precision, Place, and the Future of Cardiovascular Prediction | JACC This Week
03/11/2025
In God we trust